Concepedia

Mary C. Dunlay

MC

Statistics

Publications

4

Citations

367

H-Index

4

Active since

1985

Affiliations

United States Military Academy(Current)

Mary C. Dunlay is an author at United States Military Academy specializing in cardiovascular disease, pharmacotherapy, and medicine.

Top concepts

MedicineHypertensionPharmacologyPharmacotherapyCardiovascular DiseaseCardiovascular PharmacologyDrug DiscoveryClinical TrialsMolecular PharmacologyAntihypertensive Agents

Publications per year

1985–1996

4

Publications

4

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

Allan I. Goldberg, Mary C. Dunlay, Charles S. Sweet · The American Journal of Cardiology · 1995 · 274 citations

Hypertension, Cardiovascular Disease, Antihypertensive Agents +10

Initial Evaluation of Transdermal Timolol

Peter H. Vlasses, Lair G.T. Ribeiro, Heschi H. Rotmensch et al. · Journal of Cardiovascular Pharmacology · 1985 · 47 citations

Losartan potassium as initial therapy in patients with severe hypertension.

Mary C. Dunlay, Virginia Fitzpatrick, S Chrysant et al. · PubMed · 1995 · 23 citations

Rationale, background, and design of the randomized angiotensin receptor antagonist—Angiotensin-converting enzyme inhibitor study (RAAS)

Bertram Pitt, Paul Chang, William Grossman et al. · The American Journal of Cardiology · 1996 · 23 citations

Molecular Pharmacology, Hypertension, Cardiovascular Disease +8

1–4 of 4